H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Ca-Cancer J. Clin. 71, 209–249 (2021)

Article  PubMed  Google Scholar 

W. Chen, R. Zheng, P.D. Baade, S. Zhang, H. Zeng, F. Bray, A. Jemal, X.Q. Yu, J. He, Cancer statistics in China, 2015. Ca-Cancer J. Clin. 66, 115–132 (2016)

Article  PubMed  Google Scholar 

D. Du, C. Liu, M. Qin, X. Zhang, T. Xi, S. Yuan, H. Hao, J. Xiong, Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharm. Sin B 12, 558–580 (2022)

Article  CAS  PubMed  Google Scholar 

H.B. El-Serag, Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 142, 1264–1273 (2012)

Article  PubMed  Google Scholar 

C. Zheng, M. Liu, Y. Ge, Y. Qian, H. Fan, HBx increases chromatin accessibility and ETV4 expression to regulate dishevelled-2 and promote HCC progression. Cell. Death Dis. 13, 116 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

W. Wei, W. Huang, Y. Pan, F. Zhu, J. Wu, Functional switch of viral protein HBx on cell apoptosis, transformation, and tumorigenesis in association with oncoprotein Ras. Cancer Lett. 244, 119–128 (2006)

Article  CAS  PubMed  Google Scholar 

C. Wang, M.D. Wang, P. Cheng, H. Huang, W. Dong, W.W. Zhang, P.P. Li, C. Lin, Z.Y. Pan, M.C. Wu, W.P. Zhou, Hepatitis B virus X protein promotes the stem-like properties of OV6(+) cancer cells in hepatocellular carcinoma. Cell. Death Dis. 8, e2560 (2017)

K.J. Su, Y.L. Yu, Downregulation of SHIP2 by Hepatitis B Virus X Promotes the Metastasis and Chemoresistance of Hepatocellular Carcinoma through SKP2. Cancers. 11 (2019)

X. Lin, S. Zuo, R. Luo, Y. Li, G. Yu, Y. Zou, Y. Zhou, Z. Liu, Y. Liu, Y. Hu, Y. Xie, W. Fang, Z. Liu, HBX-induced miR-5188 impairs FOXO1 to stimulate beta-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma. Theranostics. 9, 7583–7598 (2019)

Article  CAS  PubMed  PubMed Central  Google Scholar 

M.A. Popescu, D. Patriche, M.O. Dobrica, A.M. Pantazica, A.P. Flintoaca, Y. Rouille, C.I. Popescu, Branza-Nichita, Sac1 phosphatidylinositol 4-phosphate phosphatase is a novel host cell factor regulating hepatitis B virus particles assembly and release. Febs J. 289, 7486–7499 (2022)

Article  CAS  PubMed  Google Scholar 

Y.Y. Li, K. Kuroki, T. Shimakami, K. Murai, K. Kawaguchi, T. Shirasaki, K. Nio, S. Sugimoto, T. Nishikawa, H. Okada, N. Orita, H. Takayama, Y. Wang, B.P. Thi, A. Ishida, S. Iwabuchi, S. Hashimoto, T. Shimaoka, N. Tabata, M. Watanabe-Takahashi, K. Nishikawa, H. Yanagawa, M. Seiki, K. Matsushima, T. Yamashita, S. Kaneko, M. Honda, Hepatitis B Virus utilizes a Retrograde trafficking Route via the Trans-Golgi Network to avoid lysosomal degradation. Cell. Mol. Gastroenterol. Hepatol. 15, 533–558 (2023)

Article  CAS  PubMed  Google Scholar 

F. Arnesano, G. Natile, Interference between copper transport systems and platinum drugs. Semin Cancer Biol. 76, 173–188 (2021)

Article  CAS  PubMed  Google Scholar 

M.A. Simpson, H. Cross, C. Proukakis, A. Pryde, R. Hershberger, A. Chatonnet, M.A. Patton, A.H. Crosby, Maspardin is mutated in mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia. Am. J. Hum. Genet. 73, 1147–1156 (2003)

Article  CAS  PubMed  PubMed Central  Google Scholar 

L. Zeitlmann, P. Sirim, E. Kremmer, W. Kolanus, Cloning of ACP33 as a novel intracellular ligand of CD4. J. Biol. Chem. 276, 9123–9132 (2001)

Article  CAS  PubMed  Google Scholar 

M.C. Hanna, C. Blackstone, Interaction of the SPG21 protein ACP33/maspardin with the aldehyde dehydrogenase ALDH16A1. Neurogenetics. 10, 217–228 (2009)

Article  CAS  PubMed  PubMed Central  Google Scholar 

D.P. Bartel, MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116, 281–297 (2004)

Article  CAS  PubMed  Google Scholar 

M. Wang, F. Yu, X. Chen, P. Li, K. Wang, The underlying mechanisms of noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma. Mol. Ther. -Nucl Acids. 21, 13–27 (2020)

Article  CAS  Google Scholar 

X.C. Wei, Y.R. Xia, P. Zhou, X. Xue, S. Ding, L.J. Liu, F. Zhu, Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma. World J. Gastroenterol. 27, 8302–8322 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

C.Y. Huang, X.P. Huang, J.Y. Zhu, Z.G. Chen, X.J. Li, X.H. Zhang, S. Huang, J.B. He, F. Lian, Y.N. Zhao, G.B. Wu, Mir-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients. Oncol. Rep. 33, 2889–2898 (2015)

Article  CAS  PubMed  Google Scholar 

R. Zhong, J. Tian, M. Fu, S. Ma, L. Liu, J. Li, N. Shen, J. Ke, Y. Yang, Y. Gong, Y. Zhu, Y. Wang, J. Gong, J. Chang, P. Lei, X. Cheng, K. Huang, G. Shen, X. Miao, LINC01149 variant modulates MICA expression that facilitates hepatitis B virus spontaneous recovery but increases hepatocellular carcinoma risk. Oncogene. 39, 1944–1956 (2020)

Article  CAS  PubMed  Google Scholar 

Q. Wu, W. Wu, B. Fu, L. Shi, X. Wang, K. Kuca, JNK signaling in cancer cell survival. Med. Res. Rev. 39, 2082–2104 (2019)

Article  CAS  PubMed  Google Scholar 

Y.T. Lin, Y.C. Liu, C.C. Chao, Inhibition of JNK and prothymosin-alpha sensitizes hepatocellular carcinoma cells to cisplatin. Biochem. Pharmacol. 122, 80–89 (2016)

Article  CAS  PubMed  Google Scholar 

Y. Liu, L. Liu, Y. Zhou, P. Zhou, Q. Yan, X. Chen, S. Ding, F. Zhu, CKLF1 enhances inflammation-mediated carcinogenesis and prevents Doxorubicin-Induced apoptosis via IL6/STAT3 signaling in HCC. Clin. Cancer Res. 25, 4141–4154 (2019)

Article  CAS  PubMed  Google Scholar 

B.L. Bennett, D.T. Sasaki, B.W. Murray, E.C. O’Leary, S.T. Sakata, W. Xu, J.C. Leisten, A. Motiwala, S. Pierce, Y. Satoh, S.S. Bhagwat, A.M. Manning, D.W. Anderson, SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U. S. A. 98, 13681–13686 (2001)

Z. Fang, H. Xu, J. Duan, B. Ruan, J. Liu, P. Song, J. Ding, C. Xu, Z. Li, K. Dou, L. Wang, Short-term tamoxifen administration improves hepatic steatosis and glucose intolerance through JNK/MAPK in mice. Signal. Transduct. Target. Ther. 8, 94 (2023)

Article  CAS  PubMed  PubMed Central  Google Scholar 

K. Clark, M. Langeslag, B. van Leeuwen, L. Ran, A.G. Ryazanov, C.G. Figdor, W.H. Moolenaar, K. Jalink, F.N. van Leeuwen, TRPM7, a novel regulator of actomyosin contractility and cell adhesion. Embo J. 25, 290–301 (2006)

Article  CAS  PubMed  PubMed Central  Google Scholar 

R. Zhou, Y. Chen, S. Li, X. Wei, W. Hu, S. Tang, J. Ding, W. Fu, H. Zhang, F. Chen, W. Hao, Y. Lin, R. Zhu, K. Wang, L. Dong, Y. Zhao, X. Feng, F. Chen, C. Ding, W. Hu, TRPM7 channel inhibition attenuates rheumatoid arthritis articular chondrocyte ferroptosis by suppression of the PKCalpha-NOX4 axis. Redox Biol. 55, 102411 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

M.R. Zanotelli, J. Zhang, C.A. Reinhart-King, Mechanoresponsive metabolism in cancer cell migration and metastasis. Cell. Metab. 33, 1307–1321 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Q. Jiang, N. Zheng, L. Bu, X. Zhang, X. Zhang, Y. Wu, Y. Su, L. Wang, X. Zhang, S. Ren, X. Dai, D. Wu, W. Xie, W. Wei, Y. Zhu, J. Guo, SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions. Mol. Cancer. 20, 100 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

P. Qian, A. Banerjee, Z.S. Wu, X. Zhang, H. Wang, V. Pandey, W.J. Zhang, X.F. Lv, S. Tan, P.E. Lobie, T. Zhu, Loss of SNAIL regulated mir-128-2 on chromosome 3p22.3 targets multiple stem cell factors to promote transformation of mammary epithelial cells. Cancer Res. 72, 6036–6050 (2012)

Article  CAS  PubMed  Google Scholar 

B. Su, T. Luo, J. Zhu, J. Fu, X. Zhao, L. Chen, H. Zhang, Y. Ren, L. Yu, X. Yang, M. Wu, G. Feng, S. Li, Y. Chen, H. Wang, Interleukin-1beta/Iinterleukin-1 receptor-associated kinase 1 inflammatory signaling contributes to persistent gankyrin activation during hepatocarcinogenesis. Hepatology. 61, 585–597 (2015)

Article  CAS  PubMed  Google Scholar 

M.S. Han, T. Barrett, M.A. Brehm, R.J. Davis, Inflammation mediated by JNK in myeloid cells promotes the development of Hepatitis and Hepatocellular Carcinoma. Cell. Rep. 15, 19–26 (2016)

Article  CAS  PubMed  PubMed Central  Google Scholar 

J. Li, Z.Q. Hu, S.Y. Yu, L. Mao, Z.J. Zhou, P.C. Wang, Y. Gong, S. Su, J. Zhou, J. Fan, S.L. Zhou, X.W. Huang, CircRPN2 inhibits aerobic glycolysis and metastasis in Hepatocellular Carcinoma. Cancer Res. 82, 1055–1069 (2022)

Article  CAS  PubMed  Google Scholar 

Y. Yang, P. Ren, X. Liu, X. Sun, C. Zhang, X. Du, B. Xing, PPP1R26 drives hepatocellular carcinoma progression by controlling glycolysis and epithelial-mesenchymal transition. J. Exp. Clin. Cancer Res. 41, 101 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Q. Zhang, G. Song, L. Yao, Y. Liu, M. Liu, S. Li, H. Tang, miR-3928v is induced by HBx via NF-kappaB/EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3. J. Exp. Clin. Cancer Res. 37, 14 (2018)

Article  PubMed  PubMed Central